E75.01
Sandhoff disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Sandhoff disease is a rare, inherited disorder that affects the body's ability to break down certain fats (lipids), leading to their accumulation in cells. This progressive disease primarily impacts the nervous system, causing severe neurological and physical symptoms. It is classified under the ICD-10 code E75.01 and is part of a group of disorders known as lysosomal storage diseases, which result from enzyme deficiencies that prevent proper breakdown of specific substances in cells.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations: Sandhoff disease is caused by mutations in the HEXB gene, which provide instructions for making an enzyme called hexosaminidase. A deficiency of this enzyme leads to the accumulation of harmful substances in nerve cells. Autosomal recessive inheritance: The disorder is inherited in an autosomal recessive pattern, meaning that a child needs to inherit two copies of the mutated gene—one from each parent—to develop the disease. Carrier status: Parents who are carriers typically do not show symptoms but can pass the mutated gene to their children.
Key Symptoms: Muscle weakness and hypotonia (reduced muscle tone) Loss of motor skills, such as sitting, crawling, or walking Seizures Vision and hearing loss Impaired intellectual development and cognitive decline Cherry-red spot appearance in the retina (observable during eye examination) Feeding difficulties in infants Enlarged liver and spleen (hepatosplenomegaly) Swallowing difficulties Progressive neurological deterioration leading to paralysis
Diagnostic & Treatment
Diagnosis Path: Clinical evaluation: Medical history and physical examination to identify characteristic symptoms and signs. Enzyme activity testing: Measuring levels of hexosaminidase enzymes in blood or skin cells to confirm enzyme deficiency. Genetic testing: Identification of mutations in the HEXB gene to establish a definitive diagnosis. Ophthalmological exam: Detecting the cherry-red spot in the retina, which is indicative of lysosomal storage disorders. Imaging studies: MRI scans may reveal brain atrophy or other neurological changes associated with disease progression.
Treatment Protocols: No cure exists: Currently, there is no effective treatment to stop or reverse the progression of Sandhoff disease. Symptomatic management: Supportive care such as physical therapy, occupational therapy, and speech therapy can help improve quality of life. Seizure control: Antiepileptic medications may be prescribed to manage seizures. Nutritional support: Ensuring proper nutrition to address feeding difficulties. Experimental therapies: Research is ongoing into enzyme replacement therapy, gene therapy, and other approaches, but these are not yet widely available.
Clinical Advice & FAQs
Billing Guidance
Is E75.01 a billable ICD-10 code?
Yes, E75.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E75.01?
Clinical documentation must specify the nature of Sandhoff disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference